Influenza, Human: all 2,265 studies

Page 12 of 23. Open to participants first (174), then studies with results posted, then the rest; newest registration first within each.

• InFLUenza and the HEART An Investigation Into the Acute and Lasting Cardiac Effects of Influenza InfectionCompletedNCT05084846
• Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)CompletedNCT05082688Phase 2
• ECMO for COVID-19 vs Influenza A H1N1 Associated ARDSCompletedNCT05080933
• Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4Status unknownNCT05079152Phase 4
• Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2021/22CompletedNCT05078060
• Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis PatientsStatus unknownNCT05070494Phase 4
• One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis.CompletedNCT05069714Phase 3
• Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers.CompletedNCT05060887Phase 2
• The Safety and Immunogenicity Evaluation of Live Attenuated Influenza VaccineStatus unknownNCT05056519Phase 1
• Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based SettingCompletedNCT05048589Phase 2
• Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2Active, not recruitingNCT05040659
• Proof of Concept Trial of Adjuvant Activity of SWE, a Squalene-based -Oil-in-water EmulsionWithdrawnNCT05035680Phase 1
• A Study to Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory InfectionsCompletedNCT05030324Phase 2
• Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving CladribineStatus unknownNCT05019248
• Baloxavir Versus Oseltamivir for Nursing Home Influenza OutbreaksStatus unknownNCT05012189Phase 4
• An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural BangladeshActive, not recruitingNCT04998344Phase 4
• A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years OldCompletedNCT04997239Phase 4
• Natural History of Systemic and Nasal Mucosal Immunity After Influenza Vaccination in a Pediatric PopulationCompletedNCT04963166
• Comparison of ARDS COVID-19 (WHO) vs ARDS Influenza in the ICUCompletedNCT04941092
• Comparison of COVID-19 and H1N1 Influenza PneumoniaCompletedNCT04933994
• Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®Active, not recruitingNCT04896853Phase 1
• Pharmacokinetics of Voriconazole in Adult ECMO PatientsCompletedNCT04868188
• Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/mlTerminatedNCT04810949Not applicable
• An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and OlderWithdrawnNCT04806529Phase 2/3
• Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza VaccineCompletedNCT04801888Phase 4
• Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 VaccineCompletedNCT04798677Not applicable
• Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After VaccinationCompletedNCT04794829
• Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4CompletedNCT04790851Phase 4
• Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC TestCompletedNCT04782336
• Increasing COVID-19, Influenza, and Pneumonia Vaccine UptakeWithdrawnNCT04761692Not applicable
• A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute InfluenzaCompletedNCT04736758Phase 2
• Influenza Vaccine Effectiveness of a Quadrivalent Vaccine in Pregnant Women and Young Infants, 2019-2020CompletedNCT04723771
• To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus InfectionCompletedNCT04706468Phase 2
• This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in VietnamCompletedNCT04695717Phase 3
• A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza ACompletedNCT04683406Phase 3
• Pediatric Second Influenza Dose Portal Reminder RecallCompletedNCT04668417Not applicable
• Treatment of Influenza and ARVI in Children by Kagocel ®CompletedNCT04651491
• Study to Assess Safety, Tolerability and Reactogenicity of Vaccine "UniFluVec" After Two Intranasal Administrations in Healthy VolunteersCompletedNCT04650971Phase 1
• Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like IllnessesCompletedNCT04646980Not applicable
• Kagocel® for the Prevention of ARVI and Influenza in Young PeopleCompletedNCT04626622
• High vs. Standard Dose Influenza Vaccine in Adult SOT RecipientsActive, not recruitingNCT04613206Phase 2
• Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care WorkersCompletedNCT04611061
• Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like IllnessCompletedNCT04610047Phase 2
• Cranberry Supplementation, Viral Defense, Antibody Response to the Flu ShotCompletedNCT04597554Not applicable
• Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates at a Large Retail PharmacyCompletedNCT04590066Not applicable
• Maternal and Fetal Outcomes Following Influenza Vaccination in PregnancyStatus unknownNCT04579822
• Dynamics of the Immune Responses to Repeat Influenza Vaccination ExposuresCompletedNCT04576377Phase 4
• Broadening Our Understanding of Early Versus Late Influenza Vaccine EffectivenessCompletedNCT04570904
• Attitudes Towards Influenza Vaccinations Among the Healthcare Workers of Medical University of WarsawStatus unknownNCT04569019
• Effectiveness of a Brief Intervention for Acceptance of Influenza Vaccine in the Primary Care SettingCompletedNCT04568785Not applicable
• Evaluation of Humoral Immunity Following COVID-19 in PregnancyActive, not recruitingNCT04568044
• Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4CompletedNCT04559204Phase 4
• Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai ElderlyStatus unknownNCT04548518Phase 3
• Influenza 2020/2021CompletedNCT04546854Not applicable
• Influenza Vaccine in Lung Transplant Patients - AntibodyCompletedNCT04533139
• Influenza Vaccine in Lung Transplant Patients - T CellsCompletedNCT04533061
• Influenza Vaccine in Lung Transplant Patients - Persistence of AntibodiesCompletedNCT04531787
• Influenza Vaccine in Lung Transplant Patients - SeroprotectionCompletedNCT04531657
• Prospective Observational Trial of IAPACompletedNCT04530799
• Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the SeasonCompletedNCT04530786
• Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory InfectionCompletedNCT04527614Not applicable
• Quantification of Viral Load in the Upper Respiratory Tract in Patients Treated With Olsetamivir for InfluenzaActive, not recruitingNCT04515446Not applicable
• Tomographic Findings in COVID-19 and Influenza H1N1Status unknownNCT04499378
• Tomographic Findings in COVID-19 and InfluenzaStatus unknownNCT04497311
• An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza InfectionCompletedNCT04494412Phase 2
• Single and Double Operator Techniques in Ultrasound-guided Peripheral Nerve Block Learning CurveStatus unknownNCT04487366Not applicable
• Tfh Dysfunction in HIV and AgingActive, not recruitingNCT04487041Phase 4
• Surveillance Study to Assess the Safety of Flublok Quadrivalent (Influenza Vaccine) in Pregnant Women and Their OffspringCompletedNCT04460781
• Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult SubjectsCompletedNCT04451954Phase 1
• Universal Anti-Viral Vaccine for Healthy Elderly AdultsCompletedNCT04441047Phase 1/2
• Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy AdultsCompletedNCT04439695Phase 1
• Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy InfantsCompletedNCT04381689Phase 3
• A Study to Determine the Safety and Attack Rate of the Seasonal Flu in Healthy VolunteersCompletedNCT04372719Phase 1
• Clinical Trial of Quadrivalent Influenza Virus Split VaccineCompletedNCT04363359Phase 2
• Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 InhibitorsStatus unknownNCT04355806
• COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)CompletedNCT04327791Phase 2/3
• Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination Therapy vs. Oseltamivir Alone for Hospitalised Paediatric Influenza PatientsCompletedNCT04315194
• Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-RaysStatus unknownNCT04313946
• DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)Status unknownNCT04298060Phase 2
• Different Regimens in Influenza Postexposure Chemoprophylaxis in ChildrenStatus unknownNCT04297462Not applicable
• Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing SitesCompletedNCT04288921
• Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air SamplingCompletedNCT04282135
• Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient AdultsSuspendedNCT04250311Phase 3
• Home Testing of Respiratory IllnessCompletedNCT04245800
• Burden of Influenza at Emergency Department (ED) Level in European CountriesStatus unknownNCT04244500
• Invasive Pulmonary Aspergillosis and Severe InfluenzaCompletedNCT04232956
• Limits of the Social Benefit Motive Among High-risk Patients: a Field Experiment on Influenza Vaccination BehaviourCompletedNCT04230343Not applicable
• Incidence of Influenza Infections and Determination of Vaccination Coverage Rate Among Healthcare WorkersStatus unknownNCT04223544
• Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of AgeCompletedNCT04210349Phase 3
• Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 YearsCompletedNCT04192500Phase 2
• Effect of Selenium Supplementation on Influenza VaccinationCompletedNCT04188483Not applicable
• Clinical Study of Reduning Injection for the Treatment of Influenza in ChildrenStatus unknownNCT04183725Phase 4
• Prevalence of Influenza RelAted Invasive AspergillosisCompletedNCT04172610
• Procalcitonin Role in Influenza Patients With Regard to Morbidity, Mortality and Antibiotic UseCompletedNCT04171128
• Live Attenuated Influenza Vaccine as a Nasal Model for Influenza InfectionCompletedNCT04164212Phase 4
• Burden of Influenza at Emergency Department Level : BIEDCompletedNCT04153331Not applicable
• Safety Study of Live Attenuated Influenza Vaccine, CodaVax, Delivered Via Intranasal SprayCompletedNCT04146623Phase 1
• Safety and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Formulations Containing Different H3 Hemagglutinin Antigens in Healthy Adult Subjects 18 to 30 Years of AgeCompletedNCT04144179Phase 1
• Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness PatientsStatus unknownNCT04143451Phase 3
• Lung Bacteriobiota and Influenza MortalityStatus unknownNCT04131296

← Influenza, Human overview